Neutral/Negative Catalysts
- Valuation/rally risk: stock is up ~30% year-to-date; multiple analysts explicitly say the improved outlook is largely reflected in the current price.
- Segment/margin/FCF concerns: commentary flags margin risk from contract terms and headwinds to free cash flow from higher capex and pension dynamics (FCF growth constrained into ~2029 per UBS angle).
- Flows: Hedge funds are selling (selling amount +143.99% last quarter), which can cap near-term upside.
- MACD contracting: momentum cooling increases odds of chop/range rather than a clean immediate breakout.